Clinical Trial Update: To Evaluate the Efficacy and Safety of TQC3564 Tablets in the Treatment of Persistent Allergic Rhinitis [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating TQC3564 tablets for persistent allergic rhinitis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• TQC3564

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Allergic Rhinitis | Phase 1 | Status: TERMINATED